The Natural History of Impaired Glucose Tolerance in the Pima Indians

New England Journal of Medicine

Volumn 319, Issue 23, 1988, Pages 1500-1506

  Saad, Mohammed F ^a   Knowler, William C ^a   Pettitt, David J ^a   Nelson, Robert G ^a   Mott, David M ^a   Bennett, Peter H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHNIC OR RACIAL ASPECTS; GLUCOSE TOLERANCE; HUMAN; PRIORITY JOURNAL;

EID: 0024215846     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198812083192302     Document Type: Article

References (35)

1. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039–57.
2. WHO Expert Committee on Diabetes Mellitus: second report. WHO Tech Rep Ser 1980; 646: 1–80.
3. Diabetes mellitus: report of a WHO Study Group. WHO Tech Rep Ser 1985; 727: 1–113.
4. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 yr. Diabetes 1987; 36: 523–34.
5. Jarrett RJ, Keen H, Fuller JH, McCartney M. Worsening to diabetes in men with impaired glucose tolerance (“borderline diabetes”). Diabetologia 1979; 16: 25–30.
6. Sartor G, Scherstén B, Carlström S, Melander A, Nordén Å, Persson G. Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 1980; 29: 41–9.
7. Keen H, Jarrett RJ, McCartney P. The ten-year follow-up of the Bedford survey (1962–1972): glucose tolerance and diabetes. Diabetologia 1982; 22: 73–8.
8. Sasaki A, Suzuki T, Horiuchi N. Development of diabetes in Japanese subjects with impaired glucose tolerance: a seven-year follow-up study. Diabetologia 1982; 22: 154–7.
9. Kadowaki T, Miyake Y, Hagura R, et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44–9.
10. King H, Zimmet P, Raper LR, Balkau B. The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study. Diabetologia 1984; 26: 39–43.
11. Sicree RA, Zimmet PZ, King HO, Coventry JS. Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 years. Diabetes 1987; 36: 179–86.
12. Modan M, Karasik A, Halkin H, et al. Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response: the Israel study of glucose intolerance, obesity and hypertension. Diabetologia 1986; 29: 82–9.
13. Bennett PH, Knowler WC, Pettitt DJ, Carraher MJ, Vasquez B. Longitudinal studies of the development of diabetes in the Pima Indians. In: Eschwege E, ed. Advances in diabetes epidemiology, INSERM symposium no. 22. Amsterdam: Elsevier Biomedical Press, 1982:65–74.
14. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall Study. Lancet 1980; 1: 1373–6.
15. Jarrett RJ, McCartney P, Keen H. The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79–84.
16. Bennett PH. Impaired glucose tolerance: a target for intervention? Arterisclerosis 1985; 5: 315–7.
17. Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978; 108: 497–505.
18. Herbert V, Lau K-S, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965; 25: 1375–84.
19. SAS Institute, Inc. SAS user's guide: statistics: version 5ed. Cary, N.C: SAS Institute, 1985.
20. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 18–220.
21. SAS Institute Inc. SUGI supplemental library user's guide: version 5 ed. Cary, N.C: SAS Institute, 1986.
22. Palumbo PJ, Elveback LR, Chu C-P, Connolly DC, Kurland LT. Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 194–-1970. Diabetes 1976; 25: 566–73.
23. Bennett PH. Knowler WC, Rushforth NB, Hamman RF, Savage PJ. The role of obesity in the development of diabetes in the Pima Indians. In: Vague J, Vague P. eds. Diabetes and obesity: proceedings of the fifth International Meeting of Endocrinology. Amsterdam: Excerpta-Medica, 1979:117–26.
24. Savage PJ, Dippe SE, Bennnet PH, et al. Hyperinsulinemia and hypoinsulinemia: insulin response to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes 1975; 24: 362–8.
25. Reaven G, Miller R. Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 1968; 17: 560–9.
26. Zimmet P, Whitehouse S, Alford F, Chisholm D. The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance. Diabetologia 1978; 15: 23–7.
27. Martin FIR, Wyatt GB, Griew AR, Haurahelia M, Higginbotham L. Diabetes mellitus in urban and rural communities in Papua, New Guinea: studies of prevalence and plasma insulin. Diabetologia 1980; 18: 369–74.
28. Reaven GM, Bernstein R, Davis B, Olefsky JM. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med 1976; 60: 80–8.
29. Reaven GM, Miller RG. An attempt to define the nature of chemical diabetes using a multidimensional analysis. Diabetologia 1979; 16: 17–24.
30. Nagulesparan M, Savage PJ, Mott DM, Johnson GC, Unger RH, Bennett PH. Increased insulin resistance in obese, glucose-intolerant Southwestern American Indians: evidence for a defect not explained by obesity. J Clin Endocrinol Metab 1980; 51: 739–43.
31. Lillioja S, Mott DM, Howard BV, et al. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1988; 318: 1217–25.
32. Nagulesparan M, Savage PJ, Unger RH, Bennett PH. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity. Diabetes 1979; 28: 980–3.
33. Hollenbeck CB, Chen N, Chen Y-DI, Reaven GM. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984; 33: 460–3.
34. Lillioja S, Mott DM, Zawadzki JK, et al. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 1987; 36: 1329–35.
35. Leahy JL, Bonner-Weir S, Weir GC. Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 1988; 81: 1407–14.